Additionally, biomarkers like TDP-43, has shown promise for early identification of neurodegenerative conditions like ALS, with gut-targeted therapies demonstrating potential improvements in motor function and survival [48]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.